Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

T Cell Types and Functions

T Cell Types and Functions

When T cells with CD4 markers are activated, they give rise to two types of effector cells: helper T cells and regulatory T cells. Meanwhile, T cells with CD8 markers differentiate into effector cytotoxic T cells. The differentiation of CD4 T cells into helper T cell subsets, such as Th1, Th2, and Th17 cells, is dependent on the antigen type, antigen-presenting cell, and regulatory cytokines.
Th1 cells stimulate dendritic cells to express necessary co-stimulatory molecules on their surfaces for...

T Cell Activation and Clonal Selection

T Cell Activation and Clonal Selection

T cells are integral to our adaptive immune system, recognizing and effectively responding to foreign antigens. T cell activation and clonal selection are pivotal in orchestrating this immune response. This article elucidates these mechanisms, detailing the roles of cluster of differentiation (CD) markers, major histocompatibility complex (MHC) molecules, costimulatory signals, and the process of clonal selection.
Naive T cells that have not yet encountered an antigen express two primary CD...

Autoimmune Disorders

Autoimmune Disorders

Autoimmune diseases are a group of disorders in which the body's immune system mistakenly attacks its own cells, tissues, and organs. This results from an overactive immune response against substances and tissues normally present in the body. Let's delve into the concept and mechanism of autoimmune diseases from an immune system point of view, explore different causes and examples of such diseases, and discuss potential solutions.
Concept and Mechanism of Autoimmune Diseases
The immune system...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

IL4Rα blockade inhibits proliferation of malignant lymphocytes and the immunosuppressive tumor microenvironment of mycosis fungoides.

Journal for immunotherapy of cancer·2026

Same author

Editorial: Cytokines and chemokines in lymphoma.

Frontiers in immunology·2025

Same author

IL4/IL13 Inhibition via Dupilumab Reduces Malignant T-cell Proliferation and Promotes Antitumor Immunity in Sézary Syndrome.

Cancer immunology research·2025

Same author

Dysfunctional KLRB1<sup>+</sup>CD8<sup>+</sup> T-cell responses are generated in chronically inflamed systemic sclerosis skin.

Annals of the rheumatic diseases·2025

Same author

Editorial: The underlying pathophysiology and therapeutic approaches for cutaneous T-cell lymphoma.

Frontiers in immunology·2024

Same author

The mycosis fungoides cutaneous microenvironment shapes dysfunctional cell trafficking, antitumor immunity, matrix interactions, and angiogenesis.

JCI insight·2023

Search research articles

Related Experiment Video

Updated: May 31, 2026

Imaging Features of Systemic Sclerosis-Associated Interstitial Lung Disease

Imaging Features of Systemic Sclerosis-Associated Interstitial Lung Disease

Published on: June 16, 2020

CD8+ T cells in systemic sclerosis.

Patrizia Fuschiotti¹

¹Department of Immunology, University of Pittsburgh School of Medicine, 200 Lothrop Street, BST W1052, Pittsburgh, PA 15261, USA. paf23@pitt.edu

Immunologic Research

|July 1, 2011

Summary

Systemic sclerosis (SSc) involves inflammation and fibrosis. Researchers found that specific CD8(+) T cells in SSc patients produce high levels of IL-13, a profibrotic cytokine, indicating a potential biomarker and therapeutic target.

Area of Science:

Immunology
Rheumatology
Dermatology

Background:

Systemic sclerosis (SSc) is a severe autoimmune disease marked by inflammation, fibrosis, and vascular damage.
T cell-derived cytokines are suspected contributors to the fibrotic processes in SSc.
Understanding the specific immune cell dysfunctions in SSc is crucial for developing effective treatments.

Purpose of the Study:

To investigate the role of T cells, specifically CD8(+) T cells, in the pathogenesis of Systemic sclerosis.
To identify specific cytokine profiles and molecular markers associated with SSc.
To explore potential novel therapeutic targets for SSc.

Main Methods:

Analysis of peripheral blood samples from SSc patients and healthy controls.
Quantification of cytokine production, particularly IL-13, by effector CD8(+) T cells.

More Related Videos

Development of Stem Cell-derived Antigen-specific Regulatory T Cells Against Autoimmunity

Development of Stem Cell-derived Antigen-specific Regulatory T Cells Against Autoimmunity

Published on: November 8, 2016

Related Experiment Videos

Last Updated: May 31, 2026

Imaging Features of Systemic Sclerosis-Associated Interstitial Lung Disease

Imaging Features of Systemic Sclerosis-Associated Interstitial Lung Disease

Published on: June 16, 2020

Development of Stem Cell-derived Antigen-specific Regulatory T Cells Against Autoimmunity

Development of Stem Cell-derived Antigen-specific Regulatory T Cells Against Autoimmunity

Published on: November 8, 2016

Assessment of transcription factor GATA-3 expression and correlation with clinical parameters like skin fibrosis.

Main Results:

Peripheral blood effector CD8(+) T cells from SSc patients exhibit significantly higher production of the profibrotic cytokine IL-13 compared to controls.
Elevated IL-13 levels correlate with increased expression of the transcription factor GATA-3.
This T cell phenotype is associated with the extent of skin fibrosis in SSc patients.

Conclusions:

The study identifies a specific T cell phenotype characterized by high IL-13 production in Systemic sclerosis.
This phenotype serves as a potential biomarker for immune dysfunction in SSc.
Targeting this IL-13-producing CD8(+) T cell population represents a novel therapeutic strategy for SSc.